comparemela.com

Latest Breaking News On - Hedge funds weigh in on fennec pharmaceuticals - Page 1 : comparemela.com

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells 22,222 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of the company’s stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $9.34, for a total transaction of $207,553.48. The transaction was disclosed in a legal filing with the SEC, which can be […]

Adrian Haigh Sells 22,222 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of the business’s stock in a transaction that occurred on Friday, April 19th. The stock was sold at an average price of $9.34, for a total transaction of $207,553.48. The transaction was disclosed in a filing with the Securities & Exchange […]

Fennec Pharmaceuticals (NASDAQ:FENC) Announces Earnings Results, Beats Expectations By $0 04 EPS

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) released its earnings results on Monday. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04, MarketWatch Earnings reports. The firm had revenue of $6.52 million during the quarter, compared to the consensus estimate of $5.22 million. During the same […]

HC Wainwright Cuts Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $17 00

Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its target price lowered by HC Wainwright from $18.00 to $17.00 in a research note released on Friday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.